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Background: Previous intravascular ultrasound study revealed that the major cause of in-stent restenosis was neointimal hyperplasia after 
coronary stent implantation. Although in-stent restenosis occurred even in drug-eluting stents (DES), tissue characterization of neointimal 
hyperplasia has not been fully investigated. The aim of this study is to compare neointimal tissue components between DES and bare-metal stents 
(BMS) using integrated backscatter intravascular ultrasound (IB-IVUS).
Methods: We have analyzed 6-8 months follow-up angiography in 279 lesions. Target lesion revascularization (TLR) rate was 13.5% in DES group 
and 17.5% in BMS group, respectively. We could obtain IB-IVUS data from 69 lesions, including 30 TLR lesions (12 in DES and 18 in BMS). Tissue 
characteristics in stented segments (each 0.5mm slice) were analyzed using IB-IVUS, and neointimal tissue components of each slice were divided 
by four categories (category A: calcific (-29 to -11dB), category B: dense fibrotic (-35 to -29dB), category C: fibrotic (-49 to -35dB), and category D: 
lipidic (-130 to -49dB)). We compared neointimal tissue components at the site of minimum lumen area (MLA) between DES group and BMS group. 
We also examined existence of neointimal tissue heterogeneity at the site of visible neointima by IVUS within the stented segment in each group.
Results: The pattern of in-stent restenosis was mostly focal in DES group. On the other hand, the pattern in-stent restenosis in BMS group was 
mostly diffuse proliferative. IB-IVUS analysis showed that neointimal hyperplasia was mainly composed of category C at MLA site in DES group 
(category A: 2%, category B: 7%, category C: 71%, category D: 20%). There were no significant differences of tissue components at MLA site between 
DES and BMS. Furthermore, DES, as well as BMS, had homogenous neointimal tissue characteristics throughout the stent.
Conclusions: Neointimal hyperplasia of DES was mainly composed of fibrotic tissue judging from IB-IVUS tissue characterization. In spite of the 
differences in the pattern of in-stent restenosis between DES and BMS, neointimal tissue component after DES implantation was similar to BMS.
